» Authors » Patrick Johnston

Patrick Johnston

Explore the profile of Patrick Johnston including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 98
Citations 2889
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Herrera A, Chen L, Nieto Y, Holmberg L, Johnston P, Mei M, et al.
Lancet Haematol . 2022 Nov; 10(1):e14-e23. PMID: 36403579
Background: After autologous haematopoietic stem-cell transplantation (HSCT), consolidation with brentuximab vedotin in patients with high-risk relapsed or refractory classic Hodgkin lymphoma has been shown to improve progression-free survival compared with...
12.
Baker K, Yamamoto N, Pegna A, Johnston P
Biol Psychol . 2022 Aug; 174:108422. PMID: 36038082
During visual perception, the brain must combine its predictions about what is to be perceived with incoming relevant information. The present study investigated how this process interacts with attention by...
13.
Seegobin K, Li Z, Alhaj Moustafa M, Majeed U, Wang J, Jiang L, et al.
Am J Hematol . 2022 Jun; 97(9):1150-1158. PMID: 35713565
Intravascular lymphoma (IVL) is a rare extranodal non-Hodgkin lymphoma. We performed a retrospective analysis of 55 IVL patients who were treated at our institution 2003-2018. Median age at diagnosis was...
14.
Kuhlman J, Alhaj Moustafa M, Jiang L, Iqbal M, Seegobin K, Wolcott Z, et al.
Clin Lymphoma Myeloma Leuk . 2022 May; 22(8):e815-e825. PMID: 35534379
Introduction: Leukemic involvement in high grade B cell lymphoma (L-HGBL) is rare and has been sparsely described in the literature. We report our experience in a large single institution multicenter...
15.
Desai S, Pederson L, Laplant B, Mwangi R, Maurer M, Young J, et al.
Blood Cancer J . 2022 May; 12(5):78. PMID: 35504884
Studies evaluating Positron Emission Tomography scan after 2 cycles of chemotherapy (PET2) in newly diagnosed diffuse large B cell lymphoma (DLBCL) are heterogeneous in patient characteristics, treatments and have conflicting...
16.
Phillips T, Chan H, Tam C, Tedeschi A, Johnston P, Oh S, et al.
Blood Adv . 2022 Apr; 6(11):3472-3479. PMID: 35390135
Outcomes for marginal zone lymphoma (MZL) and follicular lymphoma (FL) remain suboptimal, owing to the limited number of approved agents and the incurable nature of the diseases. BGB-3111-AU-003 was a...
17.
Kitamura H, Strodl E, Johnston P, Johnson L
Psychophysiology . 2022 Mar; 59(9):e14048. PMID: 35324013
Individual differences in the ability to habitually regulate emotion may impact the efficacy of fear memory extinction. The aim of this study was to assess the relationship between dispositional cognitive...
18.
Melody M, Gandhi S, Saunders H, Abdel-Rahman Z, Hastings J, Lengerke Diaz P, et al.
Leuk Lymphoma . 2022 Feb; 63(6):1363-1368. PMID: 35109766
Chimeric antigen receptor (CAR) T-cell therapy is effective in relapsed/refractory large B-cell lymphoma and results in a unique toxicity profile, namely cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity...
19.
Rostalski S, Robinson J, Ambrus G, Johnston P, Kovacs G
Eur J Neurosci . 2022 Jan; 55(5):1232-1243. PMID: 35064609
Identifying the faces of familiar persons requires the ability to assign several different images of a face to a common identity. Previous research showed that the occipito-temporal cortex, including the...
20.
Cull G, Burger J, Opat S, Gottlieb D, Verner E, Trotman J, et al.
Br J Haematol . 2021 Dec; 196(5):1209-1218. PMID: 34915592
The phase I/II AU-003 study in patients with treatment-naïve (TN) or relapsed/refractory (R/R) chronic lymphocytic leukaemia/small lymphocytic lymphoma demonstrated that zanubrutinib therapy results in clinically meaningful and durable responses with...